Mabel Perez
General Practice · Houston, TXNPI 1578595369
Payments from drug & device makers
Across 127 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$426
- Lilly USA, LLC$422
- Novo Nordisk$397
- Boehringer Ingelheim$212
- Amarin Pharma, Inc.$204
- Pfizer$198
- plus $776 from 14 others
What the payments were for
- Food & beverage$2,624100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $426 |
| Lilly USA, LLC | 17 | $422 |
| Novo Nordisk | 30 | $397 |
| Boehringer Ingelheim | 7 | $212 |
| Amarin Pharma, Inc. | 10 | $204 |
| Pfizer | 8 | $198 |
| Exact Sciences | 8 | $158 |
| Merck | 3 | $130 |
| Alkermes, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 3 | $70 |
| Sanofi-aventis U.S. LLC | 3 | $56 |
| Amgen | 3 | $55 |
| Abbott | 2 | $46 |
| AbbVie | 2 | $45 |
| Johnson & Johnson | 2 | $32 |
| Phadia US Inc. | 2 | $31 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Boston Scientific | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,635 in reported general payments places this provider in the 90th percentile of 8,074 general practice providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,349 |
| Atorvastatin Calcium | 67 | $824 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $696 |
| Valsartan | 18 | $601 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 19 | $503 |
| Metoprolol Succinate | 31 | $490 |
| Pravastatin Sodium | 13 | $457 |
| Levothyroxine Sodium | 42 | $443 |
| Metformin Hcl ErMetformin Hcl | 24 | $442 |
| Gabapentin | 30 | $421 |
| Ibandronate Sodium | 12 | $400 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 20 | $391 |
| Rosuvastatin Calcium | 28 | $354 |
| Losartan Potassium | 21 | $332 |
| Amlodipine Besylate | 25 | $265 |
Paid to pharmacies, not to this prescriber.
Other general practice in Houston
- Helen ShpatsHouston$3.3M
- Kelechi AzuoguHouston$2.5M
- Kathleen Szelei-StevensHouston$253K
- Zsolt GaramiHouston$111K
- Jesus MayorHouston$105K
- Azim KarimHouston$98K
- Scott ColemanHouston$87K
- Rispba McCray-GarrisonHouston$70K
- Piya GandhiHouston$36K
- Terri AlaniHouston$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.